CKD
Advertisement
Hyperkalemia and metabolic acidosis are common with CKD, and the potassium binder SZC may have benefits for both.
The National Kidney Foundation is launching an online learning tool for adults with chronic kidney disease (CKD).
Data from DISCOVER CKD was used to assess the burden and real-world treatment of hyperkalemia in CKD patients.
In a late-stage trial, Amgen will test its obesity drug candidate, MariTide, in patients at risk of kidney diseases.
What is the relationship between blood urea nitrogen-to-serum albumin ratio and mortality in ICU patients with T2D and CKD?
Sponsored content: Qasim Butt, MD, describes the importance of hyperkalemia management and how LOKELMA can help.
What role do serum free thiols play in the ability of CKD patients to mount a humoral response to SARS-CoV-2 vaccination?
It's time for another NephJC draft! This time the 2024 KDIGO CKD guideline draft is on the clock!
The American Kidney Fund introduced guidelines to help patients with chronic kidney disease manage and treat hyperkalemia.
Researchers studied the efficacy of a community pharmacist-led nutritional intervention for outpatients with CKD.
Akebia Therapeutics has ended its license agreement with CSL Vifor for Vafseo and announced WAC pricing for the anemia drug.
Members of the Nephrology Times editorial board shared the nephrology research and news they’ve found most notable this ...
Researchers conducted an analysis to quantify the within-individual variability of albuminuria in patients with T2D.
A study examined the effect of C-reactive protein on the efficacy of HIF-PHIs for anemia with CKD.
Iron replacement with ferric citrate hydrate decreased cFGF23 and normalized platelet count with anemia regardless of CKD.
FLOW trial results showed that semaglutide has significant benefits for kidney disease events, CV outcomes, and mortality.
Bhupinder Singh and Stewart Turner discussed serum bicarbonate concentrations in patients with CKD and metabolic acidosis.
Researchers examined the eligibility of patients with CKD for five cardiovascular RCTs and the reasons for ineligibility.
Ajay K. Singh discussed his findings on daprodustat dosing and utilization of finerenone.
Recognizing and managing concurrent gout and CKD is important for improving outcomes but can be difficult.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC. All rights reserved.